INTRODUCTION: Cardiopulmonary resuscitation (CPR) is often started irrespective of comorbidity or cause of arrest. We aimed to determine the prevalence of perception of inappropriate CPR of the last cardiac arrest encountered by clinicians working in emergency departments and out-of-hospital, factors associated with perception, and its relation to patient outcome. METHODS: A cross-sectional survey was conducted in 288 centres in 24 countries. Factors associated with perception of CPR and outcome were analyzed by Cochran-Mantel-Haenszel tests and conditional logistic models. RESULTS: Of the 4018 participating clinicians, 3150 (78.4%) perceived their last CPR attempt as appropriate, 548 (13.6%) were uncertain about its appropriateness and 320 (8.0%) perceived inappropriateness; survival to hospital discharge was 370/2412 (15.3%), 8/481 (1.7%) and 8/294 (2.7%) respectively. After adjusting for country, team and clinician's characteristics, the prevalence of perception of inappropriate CPR was higher for a non-shockable initial rhythm (OR 3.76 [2.13-6.64]; P < .0001), a non-witnessed arrest (2.68 [1.89-3.79]; P < .0001), in older patients (2.94 [2.18-3.96]; P < .0001, for patients >79 years) and in case of a "poor" first physical impression of the patient (3.45 [2.36-5.05]; P < .0001). In accordance, non-shockable and non-witnessed arrests were both associated with lower survival to hospital discharge (0.33 [0.26-0.41]; P < 0.0001 and 0.25 [0.15-0.41]; P < 0.0001, respectively), as were older patient age (0.25 [0.14-0.44]; P < 0.0001 for patients >79 years) and a "poor" first physical impression (0.26 [0.19-0.35]; P < 0.0001). CONCLUSIONS: The perception of inappropriate CPR increased when objective indicators of poor prognosis were present and was associated with a low survival to hospital discharge. Factoring clinical judgment into the decision to (not) attempt CPR may reduce harm inflicted by excessive resuscitation attempts.
- MeSH
- Global Health MeSH
- Adult MeSH
- Cardiopulmonary Resuscitation adverse effects statistics & numerical data MeSH
- Clinical Decision-Making MeSH
- Middle Aged MeSH
- Humans MeSH
- Perception MeSH
- Attitude of Health Personnel MeSH
- Unnecessary Procedures psychology statistics & numerical data MeSH
- Cross-Sectional Studies MeSH
- Surveys and Questionnaires MeSH
- Emergency Medical Services methods statistics & numerical data MeSH
- Out-of-Hospital Cardiac Arrest mortality therapy MeSH
- Medical Futility MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Multicenter Study MeSH
- Research Support, Non-U.S. Gov't MeSH
OBJECTIVE: The aim of this study was to construct a stratification model based on early postoperative kinetics of prostate-specific antigen (PSA) to select the most suitable high-risk patients for early intervention after radical prostatectomy (RP). MATERIALS AND METHODS: The study evaluated 205 men who had undergone RP without any adjuvant treatment. All of the patients had positive surgical margins, extracapsular extension and/or seminal vesicle invasion. The patients underwent multiple ultrasensitive PSA measurements on days 14, 30, 60 and 90 after RP, and subsequently at 3 month intervals. The ability of particular PSA measurements to predict biochemical recurrence (BCR) was assessed using the area under the curve (AUC). A sequential mathematical decision procedure was constructed to create a stratification model. RESULTS: During the median follow-up of 45.9 months, 106 patients (51%) experienced BCR. Prediction of BCR in terms of the AUC for PSA measurements on days 14, 30, 60 and 90 after the surgery was 0.61, 0.70, 0.80 and 0.82, respectively. In the multivariate analysis, only PSA after RP remained as a predictor of progression-free survival (p < 0.001). The stratification model based on calculated cut-off values for PSA on day 30 (0.068 ng/ml) and PSA on day 60 (0.015 ng/ml) reduced the potential overtreatment rate by 37%. CONCLUSIONS: The results imply that ultrasensitive PSA values obtained very early after RP correlate with the presence of recurrent disease in high-risk patients. Incorporating these readily available variables into risk stratification models may help to individualize the administration of adjuvant radiotherapy and thus to minimize overtreatment.
- MeSH
- Radiotherapy, Adjuvant MeSH
- Time Factors MeSH
- Risk Assessment methods MeSH
- Middle Aged MeSH
- Humans MeSH
- Neoplasm Recurrence, Local blood MeSH
- Prostatic Neoplasms blood radiotherapy surgery MeSH
- Area Under Curve MeSH
- Postoperative Period MeSH
- Disease-Free Survival MeSH
- Unnecessary Procedures statistics & numerical data MeSH
- Prostatectomy MeSH
- Prostate-Specific Antigen blood MeSH
- ROC Curve MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Publication type
- Journal Article MeSH
- MeSH
- Adult MeSH
- Tomography, Emission-Computed, Single-Photon methods MeSH
- Middle Aged MeSH
- Humans MeSH
- Lymphatic Metastasis MeSH
- Thyroid Neoplasms * surgery MeSH
- Postoperative Period MeSH
- Unnecessary Procedures statistics & numerical data MeSH
- Iodine Radioisotopes administration & dosage diagnostic use MeSH
- Thyroidectomy * MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Publication type
- Overall MeSH
- MeSH
- Early Detection of Cancer * MeSH
- Time Factors MeSH
- Diagnostic Errors * statistics & numerical data MeSH
- Risk Assessment statistics & numerical data MeSH
- Humans MeSH
- Mammography * methods standards trends MeSH
- Breast Neoplasms * diagnosis MeSH
- Mass Screening methods organization & administration MeSH
- Unnecessary Procedures statistics & numerical data MeSH
- Check Tag
- Humans MeSH
- Female MeSH
Před anesteziologickým výkonem je ve většině zdravotnických zařízení běžnou praxí provádět základní laboratorní vyšetření. Někdy pak (například z důvodu neprovázanosti jednotlivých informačních systémů jednotlivých zdravotnických zařízení) dochází k situaci, že jsou laboratorní vyšetření zbytečně opakována, čímž dochází ke zbytečné zátěži pacienta i k plýtvání finančních prostředků. I při velmi konzervativním odhadu jsme došli k závěru, že při důsledném sdílení dat mezi jednotlivými zdravotnickými zařízeními (například formou rozšíření systému IZIP) by bylo možné v českém zdravotnictví ušetřit nejméně 2,2 miliónu Kč ročně. I když se na první pohled může zdát tato částka jako zanedbatelná, je takovéto zjištění jasným signálem, ve kterém segmentu zdravotnictví je možné pomocí metod eHealth (zavádění výpočetní techniky do zdravotnictví) ušetřit. Při podobném sdílení například obrazových dat by byly získané úspory ještě podstatně vyšší.
A routine laboratory check-up before anesthesia is a common procedure in most hospitals in the Czech Republic. However, sometimes the examination is unnecessarily repeated due to an inaccessibility of original results. Even by taking a very conservative approach we have found possible savings of 2.2 million Czech crowns annualy by a rigorous date sharing among health care providers in the Czech Republic. Although this amount might seem insignificant, it shows a strong potentional for additional savings provided by eHeath methods when sharing X-rays, etc.
- MeSH
- Anesthesiology economics methods MeSH
- Databases as Topic MeSH
- Information Systems economics trends utilization MeSH
- Clinical Laboratory Techniques economics standards utilization MeSH
- Humans MeSH
- Costs and Cost Analysis economics statistics & numerical data MeSH
- Preoperative Care economics standards MeSH
- Unnecessary Procedures economics statistics & numerical data MeSH
- Statistics as Topic MeSH
- Cost Savings statistics & numerical data MeSH
- Medical Informatics Applications MeSH
- Check Tag
- Humans MeSH
- Geographicals
- Czech Republic MeSH
- MeSH
- Biopsy utilization MeSH
- Prostatic Hyperplasia diagnosis drug therapy surgery MeSH
- Neoplasm Invasiveness diagnosis pathology MeSH
- Comorbidity MeSH
- Quality of Life MeSH
- Humans MeSH
- Neoplasm Metastasis diagnosis therapy MeSH
- Prostatic Neoplasms complications drug therapy surgery MeSH
- Mass Screening methods trends MeSH
- Unnecessary Procedures statistics & numerical data MeSH
- Prognosis MeSH
- Prostate-Specific Antigen blood MeSH
- Neoplasm Staging methods MeSH
- Check Tag
- Humans MeSH
- Publication type
- Congress MeSH
- MeSH
- Biopsy utilization MeSH
- Neoplasm Invasiveness diagnosis pathology MeSH
- Humans MeSH
- Evidence-Based Medicine trends MeSH
- Neoplasm Metastasis diagnosis MeSH
- Prostatic Neoplasms complications MeSH
- Mass Screening methods trends utilization MeSH
- Unnecessary Procedures statistics & numerical data MeSH
- Prostate-Specific Antigen blood MeSH
- Neoplasm Staging MeSH
- Check Tag
- Humans MeSH
- Publication type
- Congress MeSH
- Geographicals
- Czech Republic MeSH
- Europe MeSH
- United States MeSH
- MeSH
- Biopsy utilization MeSH
- Neoplasm Invasiveness diagnosis pathology MeSH
- Evidence-Based Medicine trends MeSH
- Neoplasm Metastasis diagnosis MeSH
- Prostatic Neoplasms complications mortality therapy MeSH
- Mass Screening methods trends utilization MeSH
- Unnecessary Procedures statistics & numerical data MeSH
- Prostate-Specific Antigen blood MeSH
- Practice Guidelines as Topic standards MeSH
- Neoplasm Staging MeSH
- Publication type
- Congress MeSH
- Geographicals
- Europe MeSH
- United States MeSH
- Sweden MeSH
- MeSH
- Surgical Procedures, Operative classification standards adverse effects MeSH
- Diagnostic Errors MeSH
- Medical Errors prevention & control statistics & numerical data MeSH
- Humans MeSH
- Treatment Failure MeSH
- Unnecessary Procedures economics mortality statistics & numerical data MeSH
- Retrospective Studies MeSH
- Outcome and Process Assessment, Health Care history economics statistics & numerical data MeSH
- Check Tag
- Humans MeSH
- Geographicals
- United States MeSH